Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

Cipla partners with Stempeutics to launch Ciplostem, a new therapy for Knee Osteoarthritis approved by DCGI. Targets disease ...

The event also highlights the importance of non-opioid therapies for managing both acute and chronic pain. Pacira BioSciences ...

An Osaka Metropolitan University-led research team found that patients with knee osteoarthritis show a weaker human-body ...

Patients with osteoarthritis (OA) primarily affecting only one knee joint compartment did just as well with partial knee replacement (PKR) as with total arthroplasty after 10 years in a randomized ...

AMSTERDAM — Greater structural disease severity and decreased physical performance were linked to an increased risk for depression among patients with radiographic knee osteoarthritis, according to ...

Cold weather intensifies joint pain for Osteoarthritis sufferers due to reduced blood flow. While OA is irreversible, ...

Results presented here showed patella resurfacing during total knee arthroplasty may not improve outcomes in patients with ...

If the fear of joint pain or injury is keeping you from a jog or your 5K goals, never fear. Our experts have answers.

Enlivex (ENLV) reports positive Phase IIa results for Allocetra in knee osteoarthritis, showing safety and efficacy.